Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Pediatric Blood & Cancer
|
December 8, 2005
Favorable histology, MYCN-amplified 4S neonatal neuroblastoma
Edward L Chan, Richard E Harris, Kathleen H Emery, et al.
Molecular Carcinogenesis
|
October 3, 2006
Homozygous K5Cre transgenic mice have wavy hair and accelerated malignant progression in a murine model of skin carcinogenesis
Edward L Chan, Belinda E Peace, Kenya Toney, et al.
Cancer Investigation
|
September 30, 2010
Combination of phosphorylated and truncated EGFR correlates with higher tumor and nodal stage in head and neck cancer
James Keller, Kenneth R Shroyer, Shishir K Batajoo, et al.
Blood
|
January 2, 2014
A novel activating, germline JAK2 mutation, JAK2R564Q, causes familial essential thrombocytosis
S Leah Etheridge, Megan E Cosgrove, Veena Sangkhae, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 23, 2022
Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma
Jason A Chesney, Antoni Ribas, Georgina V Long, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Pediatric Blood & Cancer
|
December 8, 2005
Favorable histology, MYCN-amplified 4S neonatal neuroblastoma
Edward L Chan, Richard E Harris, Kathleen H Emery, et al.
Molecular Carcinogenesis
|
October 3, 2006
Homozygous K5Cre transgenic mice have wavy hair and accelerated malignant progression in a murine model of skin carcinogenesis
Edward L Chan, Belinda E Peace, Kenya Toney, et al.
Cancer Investigation
|
September 30, 2010
Combination of phosphorylated and truncated EGFR correlates with higher tumor and nodal stage in head and neck cancer
James Keller, Kenneth R Shroyer, Shishir K Batajoo, et al.
Blood
|
January 2, 2014
A novel activating, germline JAK2 mutation, JAK2R564Q, causes familial essential thrombocytosis
S Leah Etheridge, Megan E Cosgrove, Veena Sangkhae, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 23, 2022
Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma
Jason A Chesney, Antoni Ribas, Georgina V Long, et al.
Page
of 2